Use the DAST-10 to screen for drug-related concerns, not to make a diagnosis by itself
The Drug Abuse Screening Test-10, often called the DAST-10, is a brief screening tool used to identify possible drug-related problems. It asks 10 yes-or-no questions about drug use and related consequences, generally focused on the past 12 months. The DAST-10 does not assess alcohol or tobacco use; it focuses on nonmedical drug use and drug-related impairment [source:1].
For therapists, counselors, social workers, psychologists, psychiatrists, and other behavioral health professionals, the DAST-10 can add structure to intake, reassessment, treatment planning, and referral decisions. It gives the clinician a documented screening result, but the score should be considered alongside clinical interview data, client report, observed functioning, risk factors, diagnosis history, and treatment goals.
A DAST-10 score may support clinical decision-making. It should not be documented as a stand-alone diagnosis. A client with an elevated score may need further assessment, substance use treatment referral, harm-reduction planning, coordinated care, or ongoing monitoring. The clinician still determines what the result means in context.
What the DAST-10 measures
The DAST was originally developed as a screening measure for drug abuse problems, with the shorter DAST-10 commonly used because it is quick to administer and easy to score [source:2]. The 10-item version asks about patterns and consequences that may indicate unhealthy drug use, such as loss of control, interpersonal effects, neglect of responsibilities, medical problems, withdrawal symptoms, and concern expressed by others.
The DAST-10 produces a total score from 0 to 10. In general, higher scores suggest a greater likelihood of drug-related problems and a stronger need for further evaluation or intervention [source:1]. Because the tool is a screener, the score indicates risk or concern rather than confirming a substance use disorder diagnosis.
In clinical documentation, the most useful DAST-10 details usually include:
- The date the screening was completed
- The total score recorded by the clinician
- Relevant client statements about drug use or consequences
- Clinical follow-up, such as assessment, referral, safety planning, or treatment goal updates
Psychometric reviews have found support for the DAST as a substance use screening instrument, while also showing that performance can vary by population and setting [source:3]. That matters in documentation. A score should be written as screening data, not as proof of severity, motivation, risk, or diagnosis without additional clinical evidence.
When clinicians commonly use the DAST-10
The DAST-10 is often used during intake when a clinician needs a structured way to ask about nonmedical drug use. It can also be used when a client reports recent substance use, a referral source identifies drug-related concerns, or treatment goals involve coping skills, relapse prevention, impulse control, mood symptoms, trauma symptoms, legal stressors, family conflict, or medication adherence.
Many clinicians also use the DAST-10 during periodic reassessment. For example, a therapist may administer it at intake, then repeat it after several months if substance use becomes a treatment focus. A psychiatric provider might review DAST-10 results as part of a broader assessment of medication safety, functioning, and co-occurring symptoms. A social worker may use the result to support referral planning or care coordination.
The U.S. Preventive Services Task Force recommends screening adults for unhealthy drug use when accurate diagnosis, effective treatment, and appropriate care services can be offered or referred [source:5]. In behavioral health settings, that means the DAST-10 is most useful when the clinician has a plan for what happens next: further assessment, discussion of risk, treatment planning, referral, monitoring, or documentation of no current follow-up need.
How DAST-10 results may inform documentation
A well-documented DAST-10 result connects the score to the session context. The note should answer a practical clinical question: how did this screening result affect the clinician’s assessment, plan, or next step?
For example, a score of 0 may support documentation that the client denied current drug-related concerns during intake. A moderate or elevated score may support documentation that the clinician explored drug use patterns, assessed functional impact, discussed risks, updated treatment goals, or recommended further evaluation. A changing score over time may help document progress, worsening symptoms, or the need to modify the treatment plan.
Documentation should avoid treating the score as the entire clinical picture. A client’s DAST-10 result may be influenced by disclosure comfort, insight, recent use patterns, memory, shame, legal concerns, or misunderstanding of the questions. The note can reflect these limits in plain language: “Client completed DAST-10 and score was reviewed as a screening result. Clinician will continue assessment through interview and collateral information as appropriate.”
A practical DAST-10 documentation example
The example below shows how a clinician might document a DAST-10 result without overstating what the screening tool proves. It is not a required format. Adapt it to your clinical setting, payer requirements, state rules, and documentation policy.
Example progress note language
Assessment-related data: Client completed DAST-10 during intake. Total score: 4/10. Client reported nonmedical stimulant use on several occasions during the past year and described increased conflict with partner related to use. Client denied current withdrawal symptoms and denied current intent to use before work. Screening result reviewed with client as an indicator of possible drug-related concerns, not as a diagnosis.
Clinical intervention: Clinician used motivational interviewing strategies to explore ambivalence, perceived benefits of use, consequences, and readiness for change. Clinician assessed immediate safety and functional impact. Psychoeducation provided regarding relationship between stimulant use, sleep disruption, anxiety symptoms, and occupational functioning.
Client response: Client was engaged and stated, “I did not realize how much this was affecting my sleep.” Client expressed willingness to track use and identify triggers before next session. Client declined specialty referral at this time but agreed to revisit referral options if use increases or functioning worsens.
Plan: Add treatment goal related to reducing drug-related harm and improving coping skills for stress. Continue assessment of substance use pattern, triggers, consequences, and readiness for change. Reassess as clinically indicated.
This example keeps the clinician in control of interpretation. It records the score, relevant client report, intervention, client response, and follow-up plan. It does not say the DAST-10 diagnosed a disorder or proved a specific level of impairment.
Common documentation mistakes with the DAST-10
DAST-10 documentation problems usually come from saying too much, saying too little, or failing to connect the result to care. The goal is not to write a long paragraph for every screening. The goal is to make the note clinically meaningful and defensible.
- Documenting the score without context: “DAST-10 completed, score 5” does not explain what the clinician did with the result.
- Calling the score a diagnosis: The DAST-10 is a screening tool. Diagnosis requires clinical assessment using applicable diagnostic criteria.
- Ignoring client statements: The client’s explanation of use, consequences, risk, or motivation often matters as much as the number.
- Leaving out follow-up: If the score raises concern, the note should reflect discussion, assessment, referral, monitoring, or treatment planning.
Another frequent mistake is using vague phrases such as “substance abuse issues addressed” without identifying what was assessed or discussed. More specific wording helps: “Reviewed DAST-10 score, explored cannabis and stimulant use frequency, assessed relationship and work impact, and discussed referral options.”
How to avoid overstating DAST-10 conclusions
Clear documentation protects clinical accuracy. A screening result can support a clinical impression, but it should not carry more weight than it was designed to carry. Research on the DAST in psychiatric outpatient samples supports its usefulness as a screening measure, while also reinforcing the need for clinical context [source:4].
Use careful wording when documenting DAST-10 findings. Instead of writing, “Client has severe drug abuse based on DAST-10,” consider: “DAST-10 score suggests elevated concern for drug-related problems; clinician will complete further assessment and discuss treatment options.” This wording is more accurate and less likely to imply that the screener alone established diagnosis or severity.
Helpful documentation phrases include:
- “Score reviewed as a screening result.”
- “Findings discussed in context of clinical interview.”
- “Further assessment indicated based on score and client report.”
- “No diagnosis made based solely on screening score.”
Record keeping guidance from the American Psychological Association emphasizes that records should support quality care, continuity, and appropriate documentation of services provided [source:7]. For DAST-10 use, that means the record should show why the tool was used, what was found, and how the clinician responded.
DAST-10, ASSIST, and other substance use screening tools
The DAST-10 is one option among several substance use screening tools. Some settings use broader instruments, such as the Alcohol, Smoking and Substance Involvement Screening Test, known as the ASSIST. The ASSIST was developed for use in primary care and screens for involvement with multiple substances, including alcohol, tobacco, cannabis, cocaine, amphetamine-type stimulants, sedatives, hallucinogens, inhalants, opioids, and other drugs [source:6].
The DAST-10 may be a better fit when the clinician wants a short drug-use screener that excludes alcohol and tobacco. The ASSIST may be more appropriate when the setting needs a broader substance involvement profile. Tool choice should match the clinical question, client population, setting, training, and documentation requirements.
For therapists in private practice, the practical issue is often time. A screening tool should not create a documentation burden that discourages use. If a clinician administers a DAST-10, the note should capture the result and follow-up efficiently, without turning every screening into a long assessment report.
Where DAST-10 details fit in SOAP, DAP, and intake notes
DAST-10 results can fit into several common behavioral health note formats. The best placement depends on your documentation style and how the screening affected the session.
SOAP note placement
In a SOAP note, the client’s statements about drug use usually belong in the Subjective section. The DAST-10 score may appear in Objective if your practice treats standardized screening scores as measurable assessment data. Clinical meaning, risk level, and diagnostic considerations belong in Assessment. Follow-up, referral, treatment goal changes, or reassessment timing belong in Plan.
DAP note placement
In a DAP note, the score and relevant client report may be documented in Data. The clinician’s interpretation of the screening result, including limits and contextual factors, belongs in Assessment. Next steps belong in Plan.
Intake assessment placement
During intake, the DAST-10 result may be included in the substance use history, risk assessment, diagnostic formulation, or treatment recommendations section. If the score affects diagnosis or level-of-care planning, document the additional clinical information that supports that decision.
How AutoNotes helps document assessment-related clinical details
AutoNotes helps clinicians turn session details into structured, editable progress note drafts. For DAST-10-related documentation, the clinician remains responsible for administering the screening tool, recording the score, reviewing the client’s responses, applying clinical judgment, and finalizing the note.
AutoNotes can support the documentation step by helping organize assessment-related information you provide, such as the DAST-10 score, client comments, interventions used, client response, and plan. Instead of starting with a blank note after a full day of sessions, you can create a draft that follows a structured clinical format and then edit it for accuracy.
For example, a clinician might enter: “DAST-10 score 3, client reports cannabis use to manage sleep, denies current safety concerns, discussed sleep hygiene and coping alternatives, plan to monitor.” AutoNotes can help turn those details into a progress note draft with sections for assessment data, intervention, response, and plan. The clinician then reviews the wording, confirms accuracy, adds missing context, and finalizes the clinical record.
This is especially useful for clinicians who use standardized screenings but struggle to consistently document follow-up. The benefit is not that AI replaces assessment. The benefit is a faster starting point for a note that still reflects the clinician’s judgment.
A simple checklist for DAST-10 documentation
Before finalizing a note that includes DAST-10 results, review the record for the essentials. The note does not need to be long, but it should be clear.
- Did you document the tool name, date, and score?
- Did you include relevant client statements or context?
- Did you avoid presenting the score as a diagnosis by itself?
- Did you document clinical follow-up, even if the plan is to monitor?
If the score contributed to treatment planning, make that connection visible. If it did not change the plan, say so briefly. For example: “DAST-10 score reviewed; client denied current functional impairment related to drug use. No change to treatment plan at this time; clinician will monitor as clinically indicated.”
Build assessment documentation into your note workflow
The DAST-10 can be a useful part of behavioral health documentation when it is used as intended: a brief screening tool that supports, but does not replace, clinical assessment. Strong documentation records the score, the client’s context, the clinician’s response, and the plan.
If assessment results are one reason your notes pile up after hours, AutoNotes can help you create structured, editable drafts from the clinical details you already have. You stay in control of the final note. Start your free trial and see how AutoNotes can support faster, more consistent documentation.
References
- [source:1] Drug Abuse Screening Test (DAST-10) – University of Washington National HIV Curriculum
- [source:2] The Drug Abuse Screening Test – PubMed
- [source:3] A Comprehensive Review of the Psychometric Properties of the Drug Abuse Screening Test – PubMed
- [source:4] Psychometric Properties of the Drug Abuse Screening Test in Psychiatric Outpatients – PubMed
- [source:5] Unhealthy Drug Use: Screening – U.S. Preventive Services Task Force
- [source:6] The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Manual for Use in Primary Care – World Health Organization
- [source:7] Record Keeping Guidelines – American Psychological Association